FDA Action Alert: MacroGenics and Amgen
The Pharma Data
DECEMBER 13, 2020
MacroGenics , based in Rockville, Maryland, has a target action date of December 18 for its Biologics License Application (BLA) for margetuximab in combination with chemotherapy for patients with metastatic HER2+ breast cancer. Zai is strongly positioned to take advantage of a growing pharmaceutical market in this region.”.
Let's personalize your content